SNCA and Parkinson disease: Parkinson's disease (PD) is characterized by the progressive depletion of dopaminergic neurons in the substantia nigra pars compacta and the emergence of intraneuronal protein inclusions containing abnormal aggregations of alphasynuclein, ultimately resulting in movement disorders [1].